Dynamic Technology Lab’s Regeneron Pharmaceuticals REGN Stock Holding History

Dynamic Technology Lab’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-357	Closed	-$226K	–	1281
2025 Q1	$226K	Buy	+357	New	+$246K	0.03%	804
2024 Q1	–	Sell	-853	Closed	-$749K	–	1361
2023 Q4	$749K	Buy	+853	New	+$702K	0.08%	442
2023 Q2	–	Sell	-716	Closed	-$588K	–	1360
2023 Q1	$588K	Buy	+716	New	+$540K	0.05%	567
2022 Q3	–	Sell	-1,367	Closed	-$808K	–	1453
2022 Q2	$808K	Buy	+1,367	New	+$889K	0.09%	392
2022 Q1	–	Sell	-417	Closed	-$264K	–	1440
2021 Q4	$264K	Sell	417 -152	-27%	-$93.5K	0.03%	852
2021 Q3	$344K	Buy	+569	New	+$353K	0.04%	692
2021 Q2	–	Sell	-558	Closed	-$264K	–	1459
2021 Q1	$264K	Sell	558 -101	-15%	-$49.2K	0.03%	836
2020 Q4	$318K	Buy	+659	New	+$356K	0.05%	625
2018 Q1	–	Sell	-1,434	Closed	-$540K	–	1307
2017 Q4	$540K	Buy	+1,434	New	+$581K	0.1%	394
2016 Q3	–	Sell	-706	Closed	-$247K	–	1106
2016 Q2	$247K	Buy	+706	New	+$272K	0.07%	612

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dynamic Technology Lab's REGN Position: Q2 2025 in Review

Dynamic Technology Lab sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 357 shares — an estimated $226K sold.

Dynamic Technology Lab first reported a position in REGN in Q2 2016 and held it in 10 quarters. The position peaked at $808K in Q2 2022. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

Dynamic Technology Lab reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Dynamic Technology Lab sold 357 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $226K.
Dynamic Technology Lab first reported a position in Regeneron Pharmaceuticals in Q2 2016 and held it in 10 quarters.
Dynamic Technology Lab's Regeneron Pharmaceuticals position peaked at $808K in Q2 2022.
1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Dynamic Technology Lab's 13F filing for Q2 2025, filed 12 Aug 2025.